Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123432
Published online Nov 15, 2026. doi: 10.4251/wjgo.123432
Published online Nov 15, 2026. doi: 10.4251/wjgo.123432
Table 2 Esophagogastroduodenoscopy findings by colonoscopy concordance group (n = 379), n (%)
| EGD finding | Discordant (n = 172) | Concordant (n = 207) | P value |
| Foregut malignancy1 | 11 (6.4) | 0 (0.0) | < 0.001 |
| Premalignant lesion2 | 4 (2.3) | 16 (7.7) | 0.02 |
| Esophagitis | 18 (10.5) | 19 (9.2) | 0.73 |
| Gastritis | 40 (23.3) | 32 (15.5) | 0.07 |
| Peptic ulcer | 10 (5.8) | 9 (4.3) | 0.64 |
| GAVE | 0 (0.0) | 4 (1.9) | 0.13 |
| Gastric polyp | 14 (8.1) | 19 (9.2) | 0.86 |
| H. pylori positive | 18 (10.5) | 23 (11.1) | 0.87 |
| No abnormal findings | 94 (54.7) | 119 (57.5) | 0.60 |
- Citation: Cruz AJ, Gurram S, Obias I, Luo A, Salmastyan G, Rajagopalan A, Bui S, Sharifi R, Kumar N, Hui C, Cruz Grave E, Yang E, Erondu A, Griggs T. Foregut malignancy after discordant fecal immunochemical test: A cohort study at a United States safety-net hospital. World J Gastrointest Oncol 2026; 18(11): 123432
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123432.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123432